GSK369796, also known as N-tert-butylisoquine, is an anti-malaria drug candidate. GSK369796 was rationally designed based on chemical, toxicological, pharmacokinetic, and pharmacodynamic considerations and was selected based on excellent activity against Plasmodium falciparum in vitro and rodent malaria parasites in vivo.
仅供研究使用。 我们不向患者出售。
化学信息
名称 | GSK369796 Dihydrochloride |
Iupac 化学名称 | GSK369796 Dihydrochloride |
同义词 | GSK 369796; GSK-369796; GSK369796; N-tert-Butyl isoquine |
英文同义词 | GSK 369796; GSK-369796; GSK369796; N-tert-Butyl isoquine |
分子式 | C20H24Cl3N3O |
分子量 | |
Smile | CC(C)(C)NCc1ccc(cc1O)Nc2ccnc3c2ccc(c3)Cl.Cl |
InChiKey | BRHAHBJESRMFSW-UHFFFAOYSA-N |
InChi | InChI=1S/C20H22ClN3O.ClH/c1-20(2,3)23-12-13-4-6-15(11-19(13)25)24-17-8-9-22-18-10-14(21)5-7-16(17)18;/h4-11,23,25H,12H2,1-3H3,(H,22,24);1H |
Cas号 | 1010411-21-8 |
MDL | MFCD22566645 |
相关CAS号 | |
外观性状 | crystalline solid |
纯度 | 98% |
存储 | 3 years -20ºCpowder |
可溶性 | Soluble in DMSO |
处理方式 | |
运输条件 | Shipped under ambient temperature as non-hazardous chemical. |
海关编码 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |